DALLA COSTA, GLORIA
 Distribuzione geografica
Continente #
EU - Europa 1.946
AS - Asia 1.219
NA - Nord America 1.100
SA - Sud America 235
Continente sconosciuto - Info sul continente non disponibili 61
AF - Africa 24
OC - Oceania 2
Totale 4.587
Nazione #
RU - Federazione Russa 1.301
US - Stati Uniti d'America 1.042
SG - Singapore 456
CN - Cina 384
SE - Svezia 222
BR - Brasile 191
HK - Hong Kong 134
VN - Vietnam 108
IT - Italia 103
DE - Germania 69
FR - Francia 68
GB - Regno Unito 49
FI - Finlandia 34
CA - Canada 31
BD - Bangladesh 28
IE - Irlanda 25
IN - India 25
PL - Polonia 22
AT - Austria 21
MX - Messico 15
ES - Italia 14
IQ - Iraq 14
JP - Giappone 14
AR - Argentina 13
ZA - Sudafrica 11
ID - Indonesia 9
TR - Turchia 9
EC - Ecuador 8
CL - Cile 5
CO - Colombia 5
MA - Marocco 5
NL - Olanda 5
PY - Paraguay 5
IR - Iran 4
MY - Malesia 4
PK - Pakistan 4
SA - Arabia Saudita 4
VE - Venezuela 4
AL - Albania 3
HN - Honduras 3
NP - Nepal 3
TN - Tunisia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
EG - Egitto 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
PE - Perù 2
PH - Filippine 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
BO - Bolivia 1
DK - Danimarca 1
DZ - Algeria 1
GR - Grecia 1
GY - Guiana 1
KI - Kiribati 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
ML - Mali 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
RO - Romania 1
TH - Thailandia 1
UA - Ucraina 1
VG - Isole Vergini Britanniche 1
Totale 4.526
Città #
Singapore 218
Moscow 184
Ashburn 160
Hong Kong 132
San Jose 108
Dallas 81
Council Bluffs 67
Shanghai 67
Beijing 58
Hefei 53
Lauterbourg 47
Lawrence 46
Princeton 46
New York 43
Los Angeles 35
Hanoi 30
Santa Clara 28
Ho Chi Minh City 27
Dublin 25
Helsinki 24
São Paulo 24
Milan 23
Munich 23
Warsaw 18
Boardman 16
Manchester 14
Tokyo 14
Nuremberg 13
Orem 13
Vienna 13
Boston 12
Montreal 12
Atlanta 11
Frankfurt am Main 11
Houston 11
Phoenix 11
Poplar 11
Brooklyn 10
London 10
Chennai 9
Stockholm 9
Chicago 8
Johannesburg 8
Mexico City 8
Rio de Janeiro 8
Denver 7
Guangzhou 7
Haiphong 7
Rome 7
Cesano Boscone 6
Da Nang 6
Hải Dương 6
San Francisco 6
Turku 6
Ankara 5
Curitiba 5
Seattle 5
Tianjin 5
Baghdad 4
Bologna 4
Brasília 4
Mumbai 4
Pisa 4
Secaucus 4
Toronto 4
Belo Horizonte 3
Bengaluru 3
Bergamo 3
Biên Hòa 3
Dammam 3
Ferrara 3
Guayaquil 3
Indpls 3
Jacksonville 3
Lappeenranta 3
Miami 3
Nova Iguaçu 3
Salvador 3
Savannah 3
Sulaymaniyah 3
Wroclaw 3
Agadir 2
Annapolis 2
Assago 2
Bishkek 2
Bogotá 2
Buffalo 2
Calgary 2
Campinas 2
Caracas 2
Cincinnati 2
Columbus 2
Florence 2
Greenville 2
Guarapuava 2
Guarulhos 2
Hangzhou 2
Hortolândia 2
Itaquaquecetuba 2
Jackson 2
Totale 1.991
Nome #
Using smartphones and wearable devices to monitor behavioral changes during COVID-19 562
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicantre study 176
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response 123
Bilateral Repetitive Transcranial Magnetic Stimulation With the H-Coil in Parkinson's Disease: A Randomized, Sham-Controlled Study 115
Machine learning-driven diagnosis of multiple sclerosis from whole blood transcriptomics 113
Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimod 103
Caesarean section and infant formula feeding are associated with an earlier age of onset of multiple sclerosis 99
Repetitive Transcranial Magnetic Stimulation With H-Coil in Alzheimer's Disease: A Double-Blind, Placebo-Controlled Pilot Study 98
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis? 96
Free Light Chains and Intrathecal B Cells Activity in Multiple Sclerosis: A Prospective Study and Meta-Analysis 95
CSF extracellular vesicles and risk of disease activity after a first demyelinating event 95
Assessing seasonal dynamics of Guillain-Barré syndrome with search engine query data 94
Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes 93
Disease-modifying treatments modulate myeloid cells in multiple sclerosis patients 90
The Danger of Walking with Socks: Evidence from Kinematic Analysis in People with Progressive Multiple Sclerosis 90
Clinical significance of the number of oligoclonal bands in patients with clinically isolated syndromes. 89
High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis 89
Dysregulation of MS risk genes and pathways at distinct stages of disease 87
Fifteen years of wireless sensors for balance assessment in neurological disorders 87
Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study 85
Digital epidemiology confirms a latitude gradient of MS in France 82
From neuroimaging to clinical setting: What have we learned from migraine pain? 80
Comparative effectiveness of dimethylfumarate and fingolimod in an Italian monocentric cohort of relapsing remitting multiple sclerosis patients 77
Platelet glutamate uptake and Th1 cells inversely correlate in relapsing/remitting and in progressive multiple sclerosis 74
Early clinical and mri predictors of long-term disability in pediatric multiple sclerosis patients 72
Smart watch, smarter EDSS: Improving disability assessment in multiple sclerosis clinical practice 69
Walking-related digital mobility outcomes as clinical trial endpoint measures: Protocol for a scoping review 69
Intracortical motor conduction is associated with hand dexterity in progressive multiple sclerosis 69
MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis 69
Parry Romberg Syndrome associated with chronic facial pain. 68
Multiple biomarkers improve the prediction of multiple sclerosis in clinically isolated syndromes 68
LETTER RE: The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study 67
Refractory migraine: the role of the physician in assessment and treatment of a problematic disease 66
Prognostic value of serum neurofilaments in patients with clinically isolated syndromes 62
Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients 62
Vitamin D levels and risk of developing multiple sclerosis 61
Loss of circulating CD8+ CD161high T cells in primary progressive multiple sclerosis 61
Comparison of the 2017 and 2010 Revisions of the McDonald Criteria in Patients with CIS Suggestive of MS: A Multicentre MAGNIMS Study 60
Opinion & special articles: professionalism in neurology. Maintaining patient rapport in a world of EMR. 60
Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndrome 59
Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning. 59
Individual risk of multiple sclerosis in clinically isolated syndromes: a multicenter prospective Italian study 58
Severe disease activity in a patient with multiple sclerosis after daclizumab discontinuation 57
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome 57
The Communication of Multiple Sclerosis Diagnosis: The Patients' Perspective 55
Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study 55
Comparison of the 2017 and 2010 revisions of the mcdonald criteria in patients with cis suggestive of ms: a multicentre magnims study 55
Individual risk of multiple sclerosis in clinically isolated syndromes: a multicenter prospective Italian study 54
Prognostic Value of Vitamin D in Clinically Isolated Syndromes (CIS) 53
Reply to “Serum Neurofilaments as Candidate Biomarkers of Natalizumab Progressive Multifocal Leukoencephalopathy” 51
Overcoming recruitment challenges in patients with multiple sclerosis: Results from an Italian survey. 49
Progressive ataxia in a natalizumab-treated multiple sclerosis patient: the dark side of JC virus infection. 45
Migralepsy: a new case confirming the existence of this migraine complication and proposing therapy 43
Neurofilament light biomarkers in MS: Effects of extended natalizumab dosing 30
A wearable device perspective on the standard definitions of disability progression in multiple sclerosis 8
An overview on disease modifying and symptomatic drug treatments for multiple sclerosis 8
Neuroaxonal damage in natalizumab-treated MS patients: The role of JCV antibody titres 6
Assessing disease progression and treatment response in progressive multiple sclerosis 6
null 1
null 1
null 1
null 1
Totale 4.587
Categoria #
all - tutte 25.694
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.694


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202264 0 0 0 30 2 3 5 4 5 0 0 15
2022/2023331 115 84 27 0 0 38 23 30 13 0 1 0
2023/2024615 0 2 29 18 19 14 5 18 1 5 6 498
2024/2025734 76 25 9 16 32 47 115 67 121 53 64 109
2025/20262.572 206 163 114 399 202 108 211 219 699 132 47 72
2026/2027226 103 123 0 0 0 0 0 0 0 0 0 0
Totale 4.587